Corcept Therapeutics (CORT) Posts Wider than Expected Q4 loss of 12c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $111.81 --0%
EPS Growth %: +393.8%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +393.8%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q4 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Guggenheim Reiterates Neutral Rating on Paychex (PAYX)
- Berenberg Starts Alfa Financial Software Plc. (ALFA:LN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
